Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-30
2007-10-30
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S253120, C514S253010, C514S255020, C514S249000, C544S360000, C544S364000, C544S349000, C544S350000, C544S385000
Reexamination Certificate
active
10689865
ABSTRACT:
This invention relates to a method for treating an angiogenesis-related disease. The method includes administering to a subject in need thereof an effective amount of a piperazinedione compound having the formula:In the above formula, each ofand, independently, is a single bond or a double bond; A is H or CH(RaRb) whenis a single bond, or C(RaRb) whenis a double bond; Z is CH(RcRd) whenis a single bond, or C(RcRd) whenis a double bond; each of R1and R2, independently, is H, C(O)Re, C(O)ORe, C(O)NReRf, or SO2Re; and each of Ra, Rb, Rc, Rd, Re, and Rf, independently, is H, C1-C6alkyl, aryl, heteroaryl, C3-C8cycloalkyl, or C3-C8heterocycloalkyl; or Raand Rbtaken together are C3-C8cycloalkyl, C3-C8heterocycloalkyl, aryl, or heteroaryl; or R1and Raor R1and Rbtaken together are C3-C8cycloalkyl, C3-C8heterocycloalkyl, aryl, or heteroaryl; provided that one of Rcand Rdis aryl or heteroaryl.
REFERENCES:
patent: 4940709 (1990-07-01), Shimazaki et al.
patent: 5700804 (1997-12-01), Collins et al.
patent: 5902812 (1999-05-01), Brocchini et al.
patent: 6635649 (2003-10-01), Teng et al.
patent: 59073574 (1984-04-01), None
patent: 08151366 (1996-06-01), None
patent: WO94/04512 (1994-03-01), None
patent: 95/21832 (1995-08-01), None
patent: 01/95858 (2001-12-01), None
Bavykina et al., “Synthesis of Diketopiperazines Related to Cyclohistidylproline”, Zhurnal Obschchei Khimii, 60:148-152, 1990, XP009008684.
Hayashi, et al.Total Synthesis of Anti-microtubule Diketopiperzine Derivatives: Phenyahistin and Aurantiamine. J. Org. Chem. Dec. 1, 2000;65(24):8402-5.
Kanoh, et al.Synthesis and Biological Activities of Phenylahistin Derivatives. Bioorg. Med. Chem. Jul. 1999; 7(7): 1451-7.
Kanoh, et al.Antitumor Activity of Phenylahistin In Vitro and In Vivo. Biosci. Biotechnol. Biochem. Jun. 1999; 63(6):1130-3.
Kanoh, et al. (-)-Phenylahistin Arrests Cells In Mitosis By Inhibiting Tubulin Polymerization.. J. Antibiot (Tokyo). Feb. 1999;52(2):134-41.
Kondoh et al., Journal of Antibiotics, 51:801-804, 1998.
Kunishima et al., J. Am Chem. Soc. 121:4722-4723, 1999.
Matsunaga et al., “Isolation and Structure of Citreoindole, a New Metabolite of Hybrid Strain KO 0052 Derived from Penicillium Citreo-viride B. IFO 6200 and 4692”, Tetrahedron Letters 32:6883-6884, 1991, XP009008691.
Scakler et al., “NMR Studies on the Conformation of Cyclodipeptides with Two Identical L-aromatic Amino Acid Residues in Solutions—cyclo[-L-5(OH)Trip-L-5(OH)Trp] and cyclo[-L-Phe-L-Phe]”, Int. J. Peptide Protein Res. 38:8-14, 1991, XP009008689.
Saito et al., “Synthetic Approaches Toward Ecteinascidins. Part 1. Preparation of an (e)-2-arylidene-3-benzyl-1,5-imino-3-benzazocin-4-One Having a Protected Phenol in the E-ring”, J. Chem. Soc., Perkin Trans. 53-69, 1997, XP-002237321.
Sheinblatt, “NMR Studies on the Conformation of Aromatic Cyclodipeptides with Two Non-identical L-Aromatic Amino-acid Residues in Solution: Cyclo-[L-5(MeO)Trp-L-Tyr(Me)]”, J. Chem. Soc., Perkin Trans. 127-132, 1990, XP009008690.
Takayama et al., “Sterochemical Studies on the Uncaria Alkaloid, 3-Oxo-7-hydroxy-3,7-secorhynchophylline: The Absolute Configuration of 3-Hydroxyoxindole Derivatives”, Tetrahedron 55:6841-6846, 1999.
Chen Huei-Ting
Chen Ya-Lan
Fan Ya-Bing
Guh Jih-Hwa
Lee On
AngioRx Corporation
Bernhardt Emily
Occhiuti Rohlicek & Tsao
LandOfFree
Piperazinedione compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinedione compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinedione compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828452